# [18F]-F13640 as a New Brain Radiopharmaceutical

> **NCT03347331** · EARLY_PHASE1 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 20 (actual)

## Conditions studied

- Neurological Pathology
- Healthy Subjects

## Interventions

- **DRUG:** [18F]F13640
- **DRUG:** [18F]F13640

## Key facts

- **NCT ID:** NCT03347331
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-23
- **Primary completion:** 2021-04-23
- **Final completion:** 2021-12-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03347331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03347331, "[18F]-F13640 as a New Brain Radiopharmaceutical". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03347331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*